CD79A and COVID-19: Lastly, we noticed that individuals suffering from persistent taste or smell disorders more than one year after a mild COVID-19 had higher initial titers of saliva anti-SARS-CoV-2 IgA targeting more specifically the Spike/NTD than individuals who recovered before one year.